Quartet Medicine Garners $6,250,000 Series A Round

  • Feed Type
  • Date
    10/7/2015
  • Company Name
    Quartet Medicine
  • Mailing Address
    400 Technology Square 10th Floor Cambridge, MA 02139 USA
  • Company Description
    Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and inflammation. Human genetics and preclinical target validation data point to increased tetrahydrobiopterin (BH4) as a critical mediator of peripheral nerve dysfunction and immune cell regulation.
  • Website
    http://www.quartetmedicine.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,250,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Quartet plans to use the funding to advance its lead program focused on modulating tetrahydrobiopterin (BH4) through early clinical testing over the next two years.
  • M&A Terms
  • Venture Investor
    Remeditex Ventures
  • Venture Investor
    Undisclosed

Trending on Xconomy